These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33219444)

  • 1. Oxalobacter formigenes produces metabolites and lipids undetectable in oxalotrophic Bifidobacterium animalis.
    Chamberlain CA; Hatch M; Garrett TJ
    Metabolomics; 2020 Nov; 16(12):122. PubMed ID: 33219444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomic and lipidomic characterization of Oxalobacter formigenes strains HC1 and OxWR by UHPLC-HRMS.
    Chamberlain CA; Hatch M; Garrett TJ
    Anal Bioanal Chem; 2019 Jul; 411(19):4807-4818. PubMed ID: 30740635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of intestinal oxalate-degrading bacteria with recurrent calcium kidney stone formation and hyperoxaluria: a case-control study.
    Tavasoli S; Alebouyeh M; Naji M; Shakiba Majd G; Shabani Nashtaei M; Broumandnia N; Basiri A
    BJU Int; 2020 Jan; 125(1):133-143. PubMed ID: 31145528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forty Years of Oxalobacter formigenes, a Gutsy Oxalate-Degrading Specialist.
    Daniel SL; Moradi L; Paiste H; Wood KD; Assimos DG; Holmes RP; Nazzal L; Hatch M; Knight J
    Appl Environ Microbiol; 2021 Aug; 87(18):e0054421. PubMed ID: 34190610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sel1-like proteins and peptides are the major
    Arvans D; Chang C; Alshaikh A; Tesar C; Babnigg G; Wolfgeher D; Kron S; Antonopoulos D; Bashir M; Cham C; Musch M; Chang E; Joachimiak A; Hassan H
    Am J Physiol Cell Physiol; 2023 Jul; 325(1):C344-C361. PubMed ID: 37125773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bifidobacterium animalis subsp. lactis decreases urinary oxalate excretion in a mouse model of primary hyperoxaluria.
    Klimesova K; Whittamore JM; Hatch M
    Urolithiasis; 2015 Apr; 43(2):107-17. PubMed ID: 25269440
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Arvans D; Jung YC; Antonopoulos D; Koval J; Granja I; Bashir M; Karrar E; Roy-Chowdhury J; Musch M; Asplin J; Chang E; Hassan H
    J Am Soc Nephrol; 2017 Mar; 28(3):876-887. PubMed ID: 27738124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomic Alteration in the Mouse Distal Colonic Mucosa after Oral Gavage with
    Chamberlain CA; Hatch M; Garrett TJ
    Metabolites; 2020 Oct; 10(10):. PubMed ID: 33065971
    [No Abstract]   [Full Text] [Related]  

  • 9. Probiotic properties of Oxalobacter formigenes: an in vitro examination.
    Ellis ML; Dowell AE; Li X; Knight J
    Arch Microbiol; 2016 Dec; 198(10):1019-1026. PubMed ID: 27449000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate.
    Troxel SA; Sidhu H; Kaul P; Low RK
    J Endourol; 2003 Apr; 17(3):173-6. PubMed ID: 12803990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxalobacter formigenes and its role in oxalate metabolism in the human gut.
    Stewart CS; Duncan SH; Cave DR
    FEMS Microbiol Lett; 2004 Jan; 230(1):1-7. PubMed ID: 14734158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxalobacter formigenes: A new hope as a live biotherapeutic agent in the management of calcium oxalate renal stones.
    Hiremath S; Viswanathan P
    Anaerobe; 2022 Jun; 75():102572. PubMed ID: 35443224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy.
    Sidhu H; Schmidt ME; Cornelius JG; Thamilselvan S; Khan SR; Hesse A; Peck AB
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S334-40. PubMed ID: 10541258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxalate degrading bacteria: new treatment option for patients with primary and secondary hyperoxaluria?
    Hoppe B; von Unruh G; Laube N; Hesse A; Sidhu H
    Urol Res; 2005 Nov; 33(5):372-5. PubMed ID: 16284877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxalobacter formigenes and its potential role in human health.
    Duncan SH; Richardson AJ; Kaul P; Holmes RP; Allison MJ; Stewart CS
    Appl Environ Microbiol; 2002 Aug; 68(8):3841-7. PubMed ID: 12147479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis.
    Miller AW; Choy D; Penniston KL; Lange D
    Kidney Int; 2019 Jul; 96(1):180-188. PubMed ID: 31130222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oxalobacter formigenes--characteristics and role in development of calcium oxalate urolithiasis].
    Torzewska A
    Postepy Hig Med Dosw (Online); 2013 Nov; 67():1144-53. PubMed ID: 24379255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxalobacter formigenes Colonization and Oxalate Dynamics in a Mouse Model.
    Li X; Ellis ML; Knight J
    Appl Environ Microbiol; 2015 Aug; 81(15):5048-54. PubMed ID: 25979889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diversity of faecal oxalate-degrading bacteria in black and white South African study groups: insights into understanding the rarity of urolithiasis in the black group.
    Magwira CA; Kullin B; Lewandowski S; Rodgers A; Reid SJ; Abratt VR
    J Appl Microbiol; 2012 Aug; 113(2):418-28. PubMed ID: 22616725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperoxaluria, hypocitraturia, hypomagnesiuria, and lack of intestinal colonization by Oxalobacter formigenes in a cervical spinal cord injury patient with suprapubic cystostomy, short bowel, and nephrolithiasis.
    Vaidyanathan S; von Unruh GE; Watson ID; Laube N; Willets S; Soni BL
    ScientificWorldJournal; 2006 Apr; 6():2403-10. PubMed ID: 17619709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.